Statin-related myopathy is a clinically important cause of statin intolerance and discontinuation. In this overview, Joy and
Hegele cover the pathophysiology, epidemiology, clinical features, and management of statin-related myopathy. They discuss
options for managing statin myopathy, including statin switching, nondaily dosing regimens, nonstatin alternatives, and coenzyme
Q10 supplementation.